Positive correlation between P27(KIP1) expression and progression of human esophageal squamous cell carcinoma

International Journal of Cancer

Volumn 79, Issue 4, 1998, Pages 439-443

  Anayama, Takashi ^a   Furihata, Mutsuo ^a   Ishikawa, Tadanori ^a   Ohtsuki, Yuji ^a   Ogoshi, Shohei ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PROTEIN P27; CELL CYCLE PROTEIN; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; MICROTUBULE ASSOCIATED PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER INVASION; CELL CYCLE; ESOPHAGUS CARCINOMA; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; DISEASE COURSE; DRUG ANTAGONISM; ESOPHAGUS TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; CYCLIN E; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; PROGNOSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 0031596331     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980821)79:4<439::AID-IJC22>3.0.CO;2-Z     Document Type: Article

References (37)

1. AKAMA, Y., YASUI, W., KUNIYASU, H., YOKOZAKI, H., AKAGI, M., TAHARA, H., ISHIKAWA, T. and TAMARA, E., Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines. Jpn. J. Cancer Res ., 87, 824-830 (1996).
2. AKAMA, Y., YASUI, W., YOKOZAKI, H., KUNIYASU, H., KITAHARA, K., ISHIKAWA, T. and TAHARA, E., Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn. J. Cancer Res., 86, 617-621 (1995).
3. BLAIN, SW., MONTALVO, E. and MASSAGUÉ, J., Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) with cyclin A-cdk2 and cyclin D2-cdk4. J. biol. Chem., 272, 25863-25872 (1997).
4. BUESO-RAMOS, CE., MANSHOURI, T., HAIDAR, MA., YANG, Y. MCCOWN, P., ORDONEZ, N., GLASSMAN, A., SNEIGE, N. and ALBITAR, M., Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res. Treat., 37, 179-188 (1996).
5. CHANG, F., SYRJÄNEN, S., SHEN, Q., JI, H.X. and SYRJÄNEN, K., Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. Int. J. Cancer, 45, 21-25 (1990).
6. COATS, S., FLANAGAN, W.M., NOURSE, J. and ROBERTS, J.M., Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science, 272, 877-879 (1996).
7. COX D.R., Regression models in life tables. J. roy. Stat. Soc. [B], 34, 187-220 (1972).
8. KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1. Carcinogenesis, 18, 1139-1148 (1997).
9. EL-DEIRY, W.S., TOKINO, T., VELCULESCU, V.E., LEVY, D.B., PARSONS, R., TRENT, J.M., LIN, D., MERCER, W.E. KINZLER, K.W. and VOGELSTEIN, B., WAF1, a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
10. Kip1 and degree of malignancy in human breast and colorectal cancers. Proc. nat. Acad. Sci. (Wash.), 94, 6380-6385 (1997).
11. FURIHATA, M., ISHIKAWA, T., INOUE, A., YOSHIKAWA, C., SONOBE, H., OHTSUKI, Y. and ARAKI, K., Determination of the prognostic significance of unscheduled cyclin A overexpression in patients with esophageal squamous cell carcinoma. Clin. Cancer Res., 2, 1781-1785 (1996).
12. FURIHATA, M., OHTSUKI, Y., OGOSHI, S., TAKAHASHI, A., TAMIYA, T. and OGATA, T., Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int. J. Cancer, 54, 226-230 (1993).
13. GRAY-BABLIN, J., RAO, S. and KEYOMARSI, K., Lovastin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion. Cancer Res., 57, 604-609 (1997).
14. ISHIKAWA, T., FURIHATA, M., OHTSUKI, Y., MURAKAMI, H., INOUE, A. and OGOSHI S., Cyclin D1 overexpression related to retinoblastoma protein-expression as a prognostic marker in human esophageal squamous cell carcinoma. Brit. J. Cancer, 77, 92-97 (1998).
15. ISHIKAWA, T., FURIHATA, M., OHTSUKI, Y., ONO, H., INOUE, A. and OGOSHI, S., Aberrant expression of p53 and retinoblastoma gene products in human esophageal squampus cell carcinoma. Int. J. Oncol., 11, 1109-1114 (1997).
16. JAPANESE SOCIETY FOR ESOPHAGEAL DISEASES, GUIDELINES FOR THE CLINICAL AND PATHOLOGIC STUDIES ON CARCINOMA OF THE ESOPHAGUS, (8TH ED.), PP.2-3, KANEHARA, TOKYO (1992).
17. JIANG, W., ZHANG, Y.J., KAHN, S.M., HOLLSTEIN, M.C., SANTELLA, R.M., LU, S.H., HARRIS, C.C., MONTESANO, R. and WEINSTEIN, I.B., Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc. nat. Acad. Sci. (Wash.), 90, 9026-9030 (1993).
18. KAMB, A., GRUIS, N.A., WEAVER-FELDHAUS, J., LIU, Q., HARSHMAN, K., TAVTIGIAN, S.V., STOCKERT, E., DAY, R.S. 3RD., JOHNSON, B.E. and SKOLNICK, M.H., A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440 (1994).
19. KAPLAN, E.L. and MEIER, P., Nonparametric estimation from incomplete observations. J. Amer. Statist. Assoc., 53, 457-481 (1958).
20. KAWAMATA, N. and 12 others, Molecular analysis of the cyclin-dependent kinase inhibitor gene p27/Kip1 in human malignancies. Cancer Res., 55, 2266-2269 (1995).
21. KEYOMARSI, K., O'LEARY, N., MOLNAR, G., LEES, E., FINGERT, H.J. and PARDEE, A.B., Cyclin E, a potential prognostic marker for breast cancer. Cancer Res., 54, 380-385 (1994).
22. KITAHARA, K., YASUI, W., KUNIYASU, H., YOKOZAKI, H., AKAMA, Y., YUNOTANI, S., HISATSUGU, T. and TAMARA, E., Concurrent amplification of cyclin E and cdk2 genes in colorectal carcinomas. Int. J. Cancer. 62, 25-28 (1995).
23. LODA, M., CUKOR, B., TAM, S.W., LAVIN, P., FIORENTINO, M., DRAETTA, G.F., JESSUP, J.M. and PAGANO, M., Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature (Med.), 3, 231-234 (1997).
24. MELTZER, S.J., The molecular biology of esophageal carcinoma. Recent Results. Cancer Res., 142, 1-8 (1996).
25. MICHALIDES, R., VAN VEELEN, N., HART, A., LOFTUS, B., WIENTJENS, E. and BALM, A., Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. Cancer Res., 55, 975-978 (1995).
26. Kip1 display increased body size, multiple organ hyperplasia, retina dysplasia, and pituitary tumors. Cell, 85, 707-721 (1996).
27. 1 in mammalian fibroblasts. Science, 259, 1908-1912 (1993).
28. Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Develop., 8, 23-32 (1994).
29. Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature (Med.), 3, 222-225 (1997).
30. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. cell Biol., 14, 1669-1679 (1994).
31. KIP1 expression is inversely proportional to the proliferative index. Amer. J . Pathol., 151, 151-160 (1997).
32. Kip1 in human breast cancers. Clin. Cancer Res., 1879-1887 (1997).
33. SOOS, T.J., KIYOKAWA, H., YAN, J.S., RUBIN, M.S., GIORDANO, A., DEBLASIO, A., BOTTEGA, S., WONG, B., MENDELSOHN, J. and KOPF, A., Formation of p27-Cdk complexes during the human mitotic cell cycle. Cell Growth Differentiation., 17, 135-146 (1996).
34. TAHARA, E., Genetic alterations in human gastrointestinal cancers. Cancer (Suppl.), 75, 1410-1417 (1995).
35. 1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74 (1994).
36. Kip1. EMBO J., 16, 5334-5344 (1997).
37. Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn. J. Cancer Res., 88, 625-629 (1997).